Using Structural and Mechanistic Information to Design Novel Inhibitors/Substrates of P-Glycoprotein

Author(s): Freya Klepsch, Thomas Stockner, Thomas Erker, Markus Muller, Peter Chiba, Gerhard F. Ecker

Journal Name: Current Topics in Medicinal Chemistry

Volume 10 , Issue 17 , 2010

Become EABM
Become Reviewer
Call for Editor


Design of inhibitors of P-glycoprotein still represents a challenging task for medicinal chemists. The polyspecificity of the transporter combined with the limited structural information renders rational drug design approaches rather ineffective. Within this article we will exemplify how recent insights into structure and mechanism of Pglycoprotein may aid in design of potent inhibitors. P >

Keywords: Cyclic peptide P-glycoprotein inhibitor, ATP-binding cassette, Nucleotide binding domain, Transmembrane domain, Central nervous system, Blood brain barrier, Breast cancer related protein, Positron emission tomography, Single-photon emission computed tomography, Cytochrome P450-3A4, Multidrug resistance, MDR, Protein-ligand interaction fingerprints, Serotonine reuptake transporter, Dopamine transporter, Norepinephrine transporter, Structure activity relationship, Radiolabeled P-gp substrates, SAV1866, Ligand docking, Quinazolinones, GABAA receptor, Pharmacophore modeling, NCI-60 screening, ATPbinding site, Tyrosine kinases (TKs), Nilotinib, Dasatinib, Bosutinib, ATPases

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [1769 - 1774]
Pages: 6
DOI: 10.2174/156802610792928004
Price: $65

Article Metrics

PDF: 6